none title certification

UAB "Lotos pharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data
Financial report background

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
2,121,295
224,713
431,271
362,167
38,365
44.18
17.07
1,276,152
515,937
32,491
1,817,805
2023
1,986,806
225,517
281,967
232,782
26,422
43.42
11.72
1,095,992
594,082
18,664
1,667,765
2024
1,665,695
200,445
-85,888
-85,888
-10,335
39.81
-5.16
939,516
1,096,952
50,816
1,991,331
unlock data icon

Register and

explore Okredo data
2024
1,665,695
200,445
-85,888
-85,888
-10,335
39.81
-5.16
939,516
1,096,952
50,816
1,991,331
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

1,665,695 €Descended-16 % *

Sales per employee (€)

200,445 €Descended-11 % *

Profit before tax (€)

-85,888 €Descended-130 % *

Net Profit (€)

-85,888 €Descended-137 % *

Profit per employee (€)

-10,335 €Descended-139 % *

Total profitability (%)

39.81 %Descended-8.31 % *

Net profitability (%)

-5.16 %Descended-144.03 % *

Equity (€)

939,516 €Descended-14 % *

Amounts Payable And Liabilities (€)

1,096,952 €Ascended85 % *

Non-current Assets (€)

50,816 €Ascended172 % *

CurrentAssets (€)

1,991,331 €Ascended19 % *

*over the last year starting selected period